VP was originally identified as a disruptor of the interaction between TEAD and YAP [11], which are potent oncogenic factors in many cancers, and while it has been shown to inhibit liver cancer formation [25], the cancer suppressive mechanisms of VP require elucidation. The gene discussed is YAP1; the disease is cancer.